United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2012_register executive 2012-10-13 article Notices D09002ee1c7fc4fd3 D09002ee1c7fc5051 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant to Birich Technologies, Inc., of an exclusive evaluation option license to practice the inventions embodied in the following U.S. Patent Applications (and all continuing applications and foreign counterparts): Serial No. 61/045,088 entitled, "COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES" [HHS Ref. E-051- 2008/0-US-01]; Serial No. 61/333,512 entitled, "Peptide Inhibitors of Interferon Gamma and Interleukin 10 Signaling" [HHS Ref. E-167-2010/0- US-01]; and Serial No. 60/987,340 entitled, "Diagnostic and Therapeutic Applications of a p53 Isoform in Regenerative Medicine, Aging and Cancer" [HHS Ref. E-033-2008/0-US-01]. The patent rights in these inventions have been assigned or exclusively licensed to the Government of the United States of America. The prospective exclusive evaluation option license territory may be worldwide, and the field of use may be limited to: 77 FR 62521 https://www.govinfo.gov/app/details/FR-2012-10-15/2012-25170 2012-25170 fr15oc12-69 4140-01-P https://www.govinfo.gov/app/details/FR-2012-10-15/2012-25170 https://www.govinfo.gov/content/pkg/FR-2012-10-15/html/2012-25170.htm https://www.govinfo.gov/content/pkg/FR-2012-10-15/pdf/2012-25170.pdf 1 p. 62521 62521 77 FR 62521 Prospective Grant of Exclusive License: The Development of Therapeutic Agents for the Treatment of Metastatic Breast Cancer and T-cell Lymphoma; Federal Register Vol. 77, Issue NOTICE 2012-25170 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2012-10-30 4140-01-P 2012-25170 Notice.

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant to Birich Technologies, Inc., of an exclusive evaluation option license to practice the inventions embodied in the following U.S. Patent Applications (and all continuing applications and foreign counterparts): Serial No. 61/045,088 entitled, "COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES" [HHS Ref. E-051- 2008/0-US-01]; Serial No. 61/333,512 entitled, "Peptide Inhibitors of Interferon Gamma and Interleukin 10 Signaling" [HHS Ref. E-167-2010/0- US-01]; and Serial No. 60/987,340 entitled, "Diagnostic and Therapeutic Applications of a p53 Isoform in Regenerative Medicine, Aging and Cancer" [HHS Ref. E-033-2008/0-US-01]. The patent rights in these inventions have been assigned or exclusively licensed to the Government of the United States of America. The prospective exclusive evaluation option license territory may be worldwide, and the field of use may be limited to:

Only written comments or applications for a license (or both) which are received by the NIH Office of Technology Transfer on or before October 30, 2012 will be considered. Prospective Grants of Exclusive Licenses: Development of Therapeutic Agents for Treatment of Metastatic Breast Cancer and T-cell Lymphoma , mccuepat@mail.nih.gov Vol. 77, no. 199 Office of the Federal Register, National Archives and Records Administration 2012-10-15 continuing daily deposited born digital 795 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2012-10-15 P0b002ee183671407 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr15oc12 https://www.govinfo.gov/app/details/FR-2012-10-15 https://www.govinfo.gov/content/pkg/FR-2012-10-15/pdf/FR-2012-10-15.pdf https://www.govinfo.gov/content/pkg/FR-2012-10-15/xml/FR-2012-10-15.xml fdlp 62417 63200 DGPO 2012-10-13 2024-06-03 FR-2012-10-15 machine generated eng FR FR-2012-10-15 77 199